Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06314425 · ClinicalTrials.gov registry record · NA
Zirconia Implants: Practice-based Evidence
A NA study of Dental Implants and Ceramic Implant, sponsored by Swiss Dental Solutions.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06314425: Active NA study of Dental Implants and Ceramic Implant, sponsored by Swiss Dental Solutions.
NCT06314425 is a NA study of Dental Implants and Ceramic Implant that is active but no longer recruiting, run by Swiss Dental Solutions. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06314425, a NA study of Dental Implants and Ceramic Implant, is active but no longer recruiting, sponsored by Swiss Dental Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective case series clinical study to examine the effectiveness of Ceramic dental implants manufactured by Swiss Dental Solutions (SDS). Participants with an indication from the dentist for teeth extraction and replacement are invited to participate in this study. Participating in this study will involve the use of dental implants manufactured by Swiss Dental Solutions (SDS zirconia dental implants), submission of the case data, including pre-operative information, intra-operative details, and post-operative follow-up data, to the study site and its collaborating partners. The SDS zirconia dental implants used in this research are FDA cleared devices that are available for dental treatments.
Primary Outcome
The cumulative survival rate is determined as the percentage of implants that remained in place over the observation period for each patient. 100% of survival is defined as absence of implant loss.
Conditions Studied
Interventions
- PROCEDURE Immediate dental implants placements on fresh sockets after tooth extraction
Study Locations (1)
New Jersey
- Vizstara Professional Education - Englewood Cliffs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-03 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT06314425 still lists
NCT06314425 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Dental Implants appearing as the primary indexed condition, and to 1 intervention - of which Immediate dental implants placements on fresh sockets after tooth extraction is the first listed.
NCT06314425 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06314425 about?
NCT06314425 is a clinical study titled "Zirconia Implants: Practice-based Evidence". This study is a prospective case series clinical study to examine the effectiveness of Ceramic dental implants manufactured by Swiss Dental Solutions (SDS). Participants with an indication from the dentist for teeth extraction and replacement are invited to participate in this study. Participating i...
What is the current status of trial NCT06314425?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-01-03. Estimated completion is 2026-12-31.
What conditions does trial NCT06314425 study?
This clinical trial studies the following conditions: Dental Implants, Ceramic Implant.
What interventions are being tested in trial NCT06314425?
The interventions under investigation include: Immediate dental implants placements on fresh sockets after tooth extraction (PROCEDURE).
Who is sponsoring clinical trial NCT06314425?
This trial is sponsored by Swiss Dental Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06314425 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Implants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06314425's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI